Accueil>>Peptides>>Adrenomedullin (1-52) (porcine) (trifluoroacetate salt)

Adrenomedullin (1-52) (porcine) (trifluoroacetate salt) (Synonyms: YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDGVAPRSKISPQGY-NH2 (Cys16 and 21 bridge))

Catalog No.GC46807

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

Adrenomedullin (1-52) (porcine) (trifluoroacetate salt) Chemical Structure

Cas No.: N/A

Taille Prix Stock Qté
1 mg
427,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Adrenomedullin (1-52) is a peptide that corresponds to amino acids 1-52 of the porcine adrenomedullin sequence and contains a disulfide bond between cysteine residues at positions 16 and 21. It contains a glycine at position 40 instead of an asparagine residue as in the human adrenomedullin (1-52) sequence.1 It has been found in the porcine adrenal medulla cortex, pancreatic islet acinus and duct, and the anterior and posterior pituitary.2

1.Kitamura, K., Kangawa, K., Kojima, M., et al.Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursorFEBS Lett.338(3)306-310(1994) 2.Washimine, H., Asada, Y., Kitamura, K., et al.Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissueHistochem. Cell. Biol.103(4)251-254(1995)

Avis

Review for Adrenomedullin (1-52) (porcine) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Adrenomedullin (1-52) (porcine) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.